Sort
16,300 grants matching “fatty liver disease”
Macrophage Produced Phospholipid Transfer Protein (PLTP)
$236,875Linda K Curtiss · Scripps Research Institute, The · R21 · FY2012 · HL
Lipid metabolites can both potentiate and treat alcoholic hepatitis
$236,854Craig J McClain · University Of Louisville · U01 · FY2021 · AA
HORMONAL AND NUTRITIONAL CONTROL OF ENZYME BIOSYNTHESIS
$236,795University Of California Berkeley · R01 · FY2000 · DK
Novel PPAR-Independent Peroxisome Proliferators for Type 2 Diabetes
$236,733Lidia Nierobisz · Southeast Techinventures, Inc. · R43 · FY2011 · DK
Measuring Human BAT Volume and Activity by Quantitative and Functional MRI
$236,566Jie Deng · Lurie Children'S Hospital Of Chicago · R21 · FY2014 · DK
Gut Microbiota, Trimethylamine N-Oxide, and Endothelial Dysfunction in Middle-Aged Adults
$236,549Kevin P Davy · Virginia Polytechnic Inst And St Univ · R21 · FY2019 · AG
SLEEP AND METABOLIC CONSEQUENCES OF CHRONIC PARTIAL SLEEP RESTRICTION IN RATS
$236,547Fred W Turek · University Of Chicago · P01 · FY2012 · AG
PEROXISOME PROLIFERATOR INDUCED HEPATOCARCINOGENESIS
$236,397Northwestern University · R01 · FY2001 · CA
Acute metabolic and gene expression changes to diet
$236,380Julie Mattison · National Institute On Aging · ZIA · FY2011 · AG
Lifelong Triclosan Exposure and Fatty Liver Disease
$236,250Robert H Tukey · University Of California, San Diego · R21 · FY2020 · ES
An HTS Assay for the Discovery of Specific Inhibitors of Adipocyte FABP
$236,250J Patrick Kampf · Ffa Sciences, Llc · R21 · FY2007 · NS
Novel Knock-in mtDNA Mouse Model to Study Mitochondrial Dysfunction
$236,250Jaime Marie Ross · University Of Rhode Island · R21 · FY2025 · OD
Novel Knock-in mtDNA Mouse Model to Study Mitochondrial Dysfunction
$236,250Jaime Marie Ross · University Of Rhode Island · R21 · FY2024 · OD
Obesity and COVID-19: Role of Adipose Tissue
$236,175Tracey McLaughlin · Stanford University · R21 · FY2021 · AI
Adipocytes and Botanicals/Jacequeline M. Stephens
$235,933William T. Cefalu · Lsu Pennington Biomedical Research Ctr · P50 · FY2011 · AT
Differential risk factors for hepatocellular carcinoma in metabolic dysfunction-associated steatotic liver disease (MASLD) patients of native Hawaiians compared with US whites
$235,817Jian-Min Yuan · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · CA
ETHANOL REGULATION OF KUPFFER CELL SIGNAL TRANSDUCTION
$235,576Case Western Reserve University · R01 · FY2002 · AA
Biological Effects and Mechanistic Actions of the Natural Disaccharide and Dietary Supplement, Trehalose.
$235,563Brian Jesse Debosch · Washington University · R21 · FY2019 · AT
Animal Phenotyping (Core B)
$235,505Gary J Schwartz · Columbia University Health Sciences · P30 · FY2017 · DK
Animal Phenotyping (Core B)
$235,505Gary J Schwartz · Columbia University Health Sciences · P30 · FY2019 · DK
Physiological Significance of Conjugated Double Bonds in Membrane Lipids
$235,500Papasani V Subbaiah · University Of Illinois At Chicago · R21 · FY2008 · DK
PET-enabled Dual-energy CT
$235,500Guobao Wang · University Of California At Davis · R21 · FY2019 · EB
The Unilateral Mosaic (UMos): Novel tools to compartmentalize pathology and trace cellular interactions in mouse models of human disease
$235,500David W Gludish · Cornell University · R21 · FY2024 · OD
Taskforce for Obesity Research at Southwestern (TORS)
$235,498Jay D Horton · Ut Southwestern Medical Center · UL1 · FY2007 · RR
Collaborative Clinical Research in Nonalcoholic Steatohepatitis
$235,419Naga P. Chalasani · Indiana University Indianapolis · U01 · FY2022 · DK